Physician profile
Jay M Hamze
NPI 1356321442
$2,450.83
in general payments reported to CMS, 2019-2025
8 companies · $85.54 in 2025
The $85.54 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $185 · 2021: $886 · 2022: $308 · 2023: $213 · 2024: $460 · 2025: $85.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $759.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $723.95 | 2021-2024 | Symplicity G3, Onyx Frontier |
| Cardiovascular Systems INC. | $708.93 | 2021-2023 | Diamondback Coronary |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $334.84 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $321.00 | 2019-2020 | |
| Reflow Medical INC | $192.66 | 2024-2025 | |
| Abiomed | $120.75 | 2024-2025 | Impella |
| Abbott Laboratories | $35.00 | 2023 | Diamondback Coronary |
| Thrombolex, INC. | $13.70 | 2024 | Bashir Endovascular Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Hamze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.